| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Institute of Virology, University of Cologne, Fürst-Pückler-Str. 56, 50935 Köln, Germany1
Epidemiology and Cancer Control Program, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA2
Author for correspondence: Herbert Pfister. Fax +49 221 478 3902. e-mail herbert.pfister{at}medizin.uni-koeln.de
Genital human papillomaviruses (HPV) are considered to be one of the main risk factors for the development of cervical cancer. The P97 promoter at the E6-proximal end of the long control region (LCR) regulates the transcription of viral genes, especially the oncogenes E6 and E7. The LCR contains binding sites of several viral and cellular transcription factors, which either activate or repress the P97 promoter. Intratype variants of HPV-16 belong to six geographically clustered phylogenetic groups distributed all over the world. These variants exhibit differences in E6 protein activities and in tumour progression in vivo. Seven HPV-16 variants were investigated by sequencing the entire LCR (nt 7060–124) and by comparing the transcriptional activities of their P97 promoters. Previously unknown nucleotide variations were identified in all LCRs investigated. In luciferase assays, 3·3- and 2·8-fold increases in P97 promoter activity were detected in the Asian American c and North American 1 variants when compared with the European reference clone. The African variants 1a and 2a exhibited P97 promoter activities comparable to the European reference clone. After recombining different LCR fragments, the region responsible for enhanced transcription in the Asian American c and North American 1 variants could be attributed to the E6-proximal end of the LCR (nt 7619–124).
This article has been cited by other articles:
|
|
 |
|
  M. J. Lace, C. Isacson, J. R. Anson, A. T. Lorincz, S. P. Wilczynski, T. H. Haugen, and L. P. Turek Upstream Regulatory Region Alterations Found in Human Papillomavirus Type 16 (HPV-16) Isolates from Cervical Carcinomas Increase Transcription, ori Function, and HPV Immortalization Capacity in Culture J. Virol., August 1, 2009; 83(15): 7457 - 7466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pande, N. Jain, B. K. Prusty, S. Bhambhani, S. Gupta, R. Sharma, S. Batra, and B. C. Das Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Biopsy Samples from Cervical Cancer Patients in North India J. Clin. Microbiol., March 1, 2008; 46(3): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Calleja-Macias, L. L. Villa, J. C. Prado, M. Kalantari, B. Allan, A.-L. Williamson, L.-P. Chung, R. J. Collins, R. E. Zuna, S. T. Dunn, et al. Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16 J. Virol., November 1, 2005; 79(21): 13630 - 13640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. De la Cruz-Hernandez, A. Garcia-Carranca, A. Mohar-Betancourt, A. Duenas-Gonzalez, A. Contreras-Paredes, E. Perez-Cardenas, R. Herrera-Goepfert, and M. Lizano-Soberon Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences J. Gen. Virol., September 1, 2005; 86(9): 2459 - 2468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Hubert Variant Upstream Regulatory Region Sequences Differentially Regulate Human Papillomavirus Type 16 DNA Replication throughout the Viral Life Cycle J. Virol., May 15, 2005; 79(10): 5914 - 5922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Ordonez, A. M. Espinosa, D. J. Sanchez-Gonzalez, J. Armendariz-Borunda, and J. Berumen Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription J. Gen. Virol., June 1, 2004; 85(6): 1433 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Burk, M. Terai, P. E. Gravitt, L. A. Brinton, R. J. Kurman, W. A. Barnes, M. D. Greenberg, O. C. Hadjimichael, L. Fu, L. McGowan, et al. Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix Cancer Res., November 1, 2003; 63(21): 7215 - 7220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Berumen, R. M. Ordonez, E. Lazcano, J. Salmeron, S. C. Galvan, R. A. Estrada, E. Yunes, A. Garcia-Carranca, G. Gonzalez-Lira, and A. Madrigal-de la Campa Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: a Case-Control Study J Natl Cancer Inst, September 5, 2001; 93(17): 1325 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Watts, C. H. Thompson, Y. E. Cossart, and B. R. Rose Variable Oncogene Promoter Activity of Human Papillomavirus Type 16 Cervical Cancer Isolates from Australia J. Clin. Microbiol., May 1, 2001; 39(5): 2009 - 2014. [Abstract] [Full Text]
|
|
|
|
|
|
L. L. Villa, L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, T. Rohan, and E. L. Franco Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia J. Gen. Virol., December 1, 2000; 81(12): 2959 - 2968. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
